Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NIH × Papillomavirus Infections × Clear all

Phase

Phase 2 9 Phase NA 4 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 21 OTHER_GOV 4 INDUSTRY 4 UNKNOWN 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Anemia 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain 1 Neutropenia 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Hypothyroidism 1 Human Papillomavirus-Related Cervical Carcinoma 1 Hepatitis C, Chronic 1 Hepatitis C 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Fibrosis 1 Fatigue 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Diabetes Mellitus 1 Colonic Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 adacel 1 Tetanus Toxoid 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 Diphtheria Toxoid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡